In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) […]
Federal agencies that regulate drug pricing and healthcare insurance are concerned that an industry practice of using rebates to lower drug costs for insurers has led […]
The number of people dying from cardiovascular disease (CVD) in Asia is increasing rapidly, with over half of all CVD deaths globally in 2019 occurring in […]
More than 70 percent of adults in New York have received at least one dose of the coronavirus vaccine, meaning the last of the state’s restrictions […]